VEGFR
VEGFR (Vascular Endothelial Growth Factor Receptor) inhibitors are compounds that block the signaling of VEGFR, a key receptor in the VEGF pathway, which is crucial for angiogenesis. VEGFR inhibitors prevent the formation of new blood vessels that supply nutrients and oxygen to tumors, thereby inhibiting tumor growth. These inhibitors are widely used in cancer therapy and research to study the mechanisms of angiogenesis and develop anti-cancer treatments. At CymitQuimica, we provide a comprehensive range of high-quality VEGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Read more
Suvemcitug
CAS:1610010-57-5
Suvemcitug, an IgG1κ antibody, specifically targets vascular endothelial growth factor (VEGF) and is derived from …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80579
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
VEGFR2-IN-4
VEGFR2-IN-4 (compound 25) is a potent, selective inhibitor of the VEGFR2 kinase, exhibiting a GI50 …
Formula:
C23H20N4O3S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
432.49
Ref: TM-T78759
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
VEGFR-2-IN-29
CAS:62802-77-1
VEGFR-2-IN-29 is a VEGFR2 inhibitor.
Formula:
C16H11N3O3
Purity:
99.84%
Color and Shape:
Liquid
Molecular weight:
293.28
Ref: TM-T9979
| 1mg | 40.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 135.00 € | ||
| 25mg | 271.00 € | ||
| 50mg | 427.00 € | ||
| 100mg | 631.00 € | ||
| 500mg | 1,327.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ponatinib Hydrochloride
CAS:1114544-31-8
Ponatinib Hydrochloride (AP-24534 Hydrochloride) is a hydrochloride of ponatinib.
Formula:
C29H28ClF3N6O
Purity:
100%
Color and Shape:
Solid
Molecular weight:
569.02
Ref: TM-T2372L
| 10mg | 46.00 € | ||
| 25mg | 78.00 € | ||
| 50mg | 110.00 € | ||
| 100mg | 167.00 € | ||
| 200mg | 240.00 € | ||
| 500mg | 407.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
T-1-MCPAB
T-1-MCPAB, a VEGFR-2 inhibitor with an IC50 of 0.135 µM, effectively suppresses MCF7 cell migration …
Purity:
98%
Ref: TM-T81054
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
hCA/VEGFR-2-IN-2
Compound 8g (hCA/VEGFR-2-IN-2) is an indolinonylbenzenesulfonamide identified as a potential dual inhibitor targeting cancer-associated isozymes …
Formula:
C23H26N6O5S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
498.55
Ref: TM-T79587
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
5Z-7-Oxozeaenol
CAS:253863-19-3
5Z-7-Oxozeaenol: TGF-β-activated kinase 1 inhibitor, IC50 8.1 nM; VEGF-R2 inhibitor, IC50 52 nM; weak MEK1 …
Formula:
C19H22O7
Purity:
99%
Color and Shape:
Solid
Molecular weight:
362.37
Ref: TM-T14055
| 1mg | 414.00 € | ||
| 5mg | 1,038.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ranibizumab
CAS:347396-82-1
Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth …
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
149.19KD
Ref: TM-T9928
| 1mg | 305.00 € | ||
| 5mg | 815.00 € | ||
| 10mg | 1,303.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
SU 4981
CAS:186610-88-8
SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.
Formula:
C19H18N2O2
Purity:
100%
Color and Shape:
Soild
Molecular weight:
306.36
Ref: TM-T60094
| 1mg | 111.00 € | ||
| 5mg | 240.00 € | ||
| 10mg | 356.00 € | ||
| 25mg | 543.00 € | ||
| 50mg | 759.00 € | ||
| 100mg | 1,017.00 € | ||
| 200mg | 1,356.00 € | ||
| 1mL*10mM (DMSO) | 239.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Conbercept
CAS:1227158-72-6
Conbercept (KH902) is a fusion protein comprising the second immunoglobulin C-like domain of FLT1 and …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80595
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
VEGFR-2-IN-32
VEGFR-2-IN-32 (Comp 3a) is an inhibitor of VEGFR-2, exhibiting an inhibitory concentration (IC 50) of …
Formula:
C15H12N4O
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
264.28
Ref: TM-T79495
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
VEGFR-2-IN-33
VEGFR-2-IN-33 (Compound 4d), a potent VEGFR inhibitor with an IC50 value of 61.04 nM, demonstrates …
Formula:
C20H14N6O2S2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
434.49
Ref: TM-T78819
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
VEGFR-2/InhA-IN-1
VEGFR-2/InhA-IN-1, a dual inhibitor based on pyrazole, targets InhA and VEGFR, exhibiting both anti-tuberculosis and …
Formula:
C22H16ClFN4O
Color and Shape:
Liquid
Molecular weight:
406.84
Ref: TM-T200074
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
VEGFR-2-IN-36
VEGFR-2-IN-36 (compound 15) serves as a potent VEGFR-2 inhibitor, exhibiting an IC50 value of 0.067 …
Formula:
C24H23N7O5
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
489.48
Ref: TM-T79403
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
FGFR1/VEGFR2-IN-1
FGFR1/VEGFR2-IN-1 (compound 2b) is an inhibitor of both FGFR1 and VEGFR2, applicable in cancer research …
Formula:
C26H27N4O6P
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
522.49
Ref: TM-T78845
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Icrucumab
CAS:1024603-92-6
Icrucumab, a humanized antibody, inhibits VEGFR-1 and shows antitumor effects, tested in metastatic colon cancer.
Purity:
> 95%
Color and Shape:
Liquid
Molecular weight:
150 kDa
Ref: TM-T76866
| 1mg | 211.00 € | ||
| 5mg | 610.00 € | ||
| 10mg | 928.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Motesanib Diphosphate
CAS:857876-30-3
Motesanib Diphosphate (AMG 706) is the orally bioavailable diphosphate salt of a multiple-receptor tyrosine kinase …
Formula:
C22H23N5O·2H3PO4
Purity:
99.76%
Color and Shape:
Solid
Molecular weight:
569.44
Ref: TM-T2288L
| 5mg | 42.00 € | ||
| 10mg | 56.00 € | ||
| 25mg | 94.00 € | ||
| 50mg | 166.00 € | ||
| 100mg | 276.00 € | ||
| 500mg | 677.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Jaceidin
CAS:10173-01-0
Jaceidin (Quercetagetin 3,3',6-trimethyl ether) is a membrane-permeable inhibitor of VEGFR with anti-tumor activities.
Formula:
C18H16O8
Purity:
98%
Color and Shape:
Solid
Molecular weight:
360.31
Ref: TM-TN4343
| 1mg | 652.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Faricimab
CAS:1607793-29-2
Faricimab, a bispecific antibody, simultaneously targets angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A), and is …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T78253
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
VEGFR-2-IN-35
VEGFR-2-IN-35 (compound 7) is a potent inhibitor of VEGFR-2, exhibiting an IC50 of 37 nM.
Formula:
C25H19N3O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
409.44
Ref: TM-T79400
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
